BCIQ Profiles

Company Profile Report

SK becomes Korea’s third-largest public healthcare company after $800M IPO

Neurology company SK more than doubled its value to $8 billion on its first day of trading Thursday after raising just under $800 million in the largest biotech IPO in Korea

Read the full 311 word article

How to gain access

Continue reading with a
two-week free trial.